SOD1 and amyotrophic lateral sclerosis: However, pioglitazone treatment, which acts on the melanocortin pathway in the arcuate nucleus, failed to stimulate body weight gain in ALS patients and in SOD1 mice, suggesting that a breakdown of central processes that regulate energy homeostasis may contribute to alter appetite and body weight in ALS (Vercruysse et al., 2016).